Hypothermic circulatory arrest in octogenarians: risk of stroke and mortality

J R Liddicoat1, J M Redmond, C M Vassileva

  • 1Division of Cardiac Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

Insights

Deep hypothermic circulatory arrest (DHCA) in patients aged 80+ undergoing cardiovascular procedures shows acceptable mortality but a higher stroke risk. Long-term survival remains satisfactory for this elderly demographic.

Area of Science:

  • Cardiovascular Surgery
  • Geriatric Medicine
  • Neurological Outcomes

Background:

  • Increasing number of elderly patients (80+) undergoing complex cardiovascular procedures.
  • Growing need to assess risks associated with advanced surgical techniques in this population.

Purpose of the Study:

  • To quantify stroke and mortality risks of deep hypothermic circulatory arrest (DHCA) in patients in their ninth decade.
  • To evaluate the safety and efficacy of DHCA in elderly patients undergoing cardiovascular surgery.

Main Methods:

  • Retrospective analysis of 251 adult patients undergoing cardiovascular procedures with DHCA since 1989.
  • Comparison of outcomes between 20 patients aged 80+ (Group I) and 231 patients <80 years (Group II).
  • Inclusion of 632 elderly patients (80+) who had cardiopulmonary bypass without DHCA (Group III) as a control.

Main Results:

  • 30-day mortality: 5% (Group I), 15.2% (Group II), 8.2% (Group III).
  • Stroke rate: 20% (Group I), 8.8% (Group II), 6.5% (Group III).
  • Elderly patients (Group I) had a significantly higher stroke rate compared to younger patients (Group II).

Conclusions:

  • Deep hypothermic circulatory arrest (DHCA) is feasible in patients in their ninth decade with acceptable early mortality.
  • Elderly patients undergoing DHCA face an elevated risk of stroke.
  • Satisfactory late survival rates suggest long-term benefits for carefully selected elderly patients.
Abstract

Related Concept Videos

Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by sustained extreme cold exposure, and severe...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...